Target intelligence / Profile preview

Eukaryotic translation initiation factor 4A1 pseudogene 2 (EIF4A1P2)

Target
EIF4A1P2
Molecular classification
Other (pseudogene)
01

Overview

Eukaryotic translation initiation factor 4A1 pseudogene 2 (EIF4A1P2) is a non-coding pseudogene related to EIF4A1, which itself is a DEAD-box RNA helicase vital to eukaryotic mRNA translation initiation[2][3][4]. Pseudogenes such as EIF4A1P2 arise when duplicated or mutated versions of functional genes lose protein-coding ability. EIF4A1P2 is annotated in human genome databases but does not produce a functional protein, nor is it involved in translation, cellular signaling, disease biology, or targeted by any drugs. By contrast, EIF4A1 (eukaryotic translation initiation factor 4A1) is a well-characterized ATP-dependent RNA helicase, part of the eIF4F complex that unwinds mRNA secondary structures to facilitate ribosome recruitment and cap-dependent translation[2][3][4]. EIF4A1 is involved in cell proliferation, immune cell development, and acts as an oncogene in some cancers[1][4], but no such biological or therapeutic relevance applies to EIF4A1P2. EIF4A1P2 is an example of a gene name that may appear in bioinformatic searches but should not be listed as a drug target or functional receptor/enzyme/transporter. If querying for potential drug targets, focus on the parent gene EIF4A1 and not this pseudogene. If you intended to refer to EIF4A1 rather than its pseudogene, there is an error or misannotation in your query. EIF4A1P2 itself does not have known biological function, disease relevance, mechanism of action, or drug interactions.

Other names
EIF4A1P2
02

Biological functions

Other (no known biological function; does not encode functional protein)
03

Disease associations

Other (no established disease associations)

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 4A1 pseudogene 2 (EIF4A1P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 4A1 pseudogene 2 (EIF4A1P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call